AND EXCHANGE COMMISSION
of Foreign Private Issuer
to Rule 13a-16 or 15d-16
Securities Exchange Act of 1934
the month of August 2019
File Number: 001-37643
of registrant’s name into English)
Azrieli Center, Round Tower,
Menachem Begin Road, Tel Aviv 6701101, Israel
of principal executive offices)
by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.
20-F ☒ Form 40-F ☐
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ____
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ____
Pharma Ltd. (the “Company” or the “Registrant”) is announcing that on August 14, 2019, the
Company issued a press release, “
Administrative Enforcement Agreement Finalized between Kitov Pharma and the Israeli
, which is attached hereto as Exhibit 99.1.
to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.
CEO & CFO